Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus (Q43853047)

27 November 2017

Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus (English)

1 reference

27 November 2017

1 reference

Human metapneumovirus

object named as

Human metapneumovirus

1 reference

6

1 reference

27 November 2017

Peter Hopkins

1

1 reference

27 November 2017

Keith McNeil

2

1 reference

27 November 2017

Fiona Kermeen

3

1 reference

27 November 2017

Michael Musk

4

1 reference

27 November 2017

Emily McQueen

5

1 reference

27 November 2017

Terry Sloots

7

1 reference

27 November 2017

Michael Nissen

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

24 July 2008

1 reference

American Journal of Respiratory and Critical Care Medicine

27 November 2017

1 reference

27 November 2017

178

1 reference

27 November 2017

876-881

1 reference

27 November 2017

8

1 reference

Parainfluenza and influenza virus infections in pediatric organ transplant recipients.

27 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Community respiratory viruses: organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Respiratory viruses and severe lower respiratory tract complications in hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Human metapneumovirus detection in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Human Metapneumovirus Infection in the Canadian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

High seroprevalence of human metapneumovirus among young children in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

A single-season prospective study of respiratory viral infections in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Latency and persistence of respiratory syncytial virus despite T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Community respiratory viral infection in adult lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200711-1657OC

10.1164/RCCM.200711-1657OC

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference